oral vs injection tirzepatide GLP-1 Drops Injection, Pros, Cons, And Reality Explained TrimRX | Oral Tirzepatide: Everything

A drug approved for diabetes has now been shown to also help patients with diabetes lose on average 10 percent of their body weight, UT Southwestern reports in a landmark international study.

Semaglutide data were analyzed to assess effects of treatment as a function of CV risk predicted using the CV risk prediction model

While we await approval, this is our moment to deepen conversations with patients about realistic treatment expectations, the science of combination therapy, and sustainable metabolic resetnot just the numbers on the scale

To help people figure out who qualifies, whats involved and what to expect for first-time GLP-1 users, a pair of weight management specialists at MUSC Health sat down for this Q&A.

This comparison is not as simple as 'tirzepatide wins, use tirzepatide.' The full picture is more nuanced.